Sea Moss for Undifferentiated Connective Tissue Disease: ANA Support, Anti-Inflammatory & Early CTD Nutrition

Undifferentiated connective tissue disease (UCTD) describes patients with clinical features and ANA-positive serology suggesting a connective tissue disease who do not yet meet criteria for SLE, SSc, Sjogren's, or another defined CTD. UCTD affects an estimated 100,000+ Americans and may progress to a defined CTD in 15-35% of cases. Sea moss fucoidan modulates ANA-associated B-cell and complement activation; selenium supports multi-organ GPx antioxidant protection during this evolving phase; zinc supports Treg immune regulation to potentially modulate disease trajectory; omega-3 precursors modulate Raynaud's and inflammatory eicosanoids common in UCTD. Hydroxychloroquine is often used in UCTD; close rheumatologist monitoring for progression is essential; sea moss provides foundational anti-inflammatory nutritional support.

Read the full guide